ホーム>>Lipids>> Octadecanoids>>Oleoyl Serinol

Oleoyl Serinol (Synonyms: NOleoyl Serinol, S18)

カタログ番号GC44502

オレオイルセリノールは、セラミドのアナログであり、カンナビノイド受容体GPR119のアゴニストであり、マウス内分泌GLUTag細胞におけるGLP-1分泌を刺激するEC50値が12μMです。

Products are for research use only. Not for human use. We do not sell to patients.

Oleoyl Serinol 化学構造

Cas No.: 72809-08-6

サイズ 価格 在庫数 個数
5mg
$57.00
在庫あり
10mg
$108.00
在庫あり
50mg
$452.00
在庫あり
100mg
$792.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Oleoyl serinol is an analog of ceramide and an agonist of the cannabinoid receptor GPR119 that has an EC50 value of 12 µM for stimulating secretion of GLP-1 in mouse endocrine GLUTag cells. It has been found in E. coli that express human microbiota N-acyl synthase (hmNAS) genes. It induces cell death of F-11 murine neuroblastoma and apoptosis in U-87 human astrocytoma cells when used at a concentration of 100 µM. Oleoyl serinol (80 µM) induces formation of a complex including PAR-4 and PKCζ in embryoid body-derived cells, decreases the levels of the pluripotency marker Oct-4 and prostate apoptosis response-4 (PAR-4), which mediates ceramide-induced apoptosis in embryonic stem cells. It induces apoptosis selectively in rapidly dividing cells over differentiated cells as well as prevents teratoma formation and promotes neural differentiation in a neonatal mouse engraftment model of teratoma formation.

レビュー

Review for Oleoyl Serinol

Average Rating: 5 ★★★★★ (Based on Reviews and 28 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Oleoyl Serinol

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.